エピソード

  • Blocking Malaria Transmission with PfPIMMS43 Nanobodies (April 2025)
    2025/05/03
    Briefing Document: Nanobody-Mediated Blocking of Malaria Transmission Targeting PfPIMMS43Source: Excerpts from "s42003-025-08033-8.pdf" (A Nature Portfolio journal; https://doi.org/10.1038/s42003-025-08033-8) Authors: Chiamaka Valerie Ukegbu, et al. Date: Received - 04 December 2024 | Accepted - 02 April 2025 | Published - 30 April 2025Executive Summary:This study explores a novel strategy to block malaria transmission by targeting the Plasmodium falciparum protein PfPIMMS43 using single-domain VHH antibodies, also known as nanobodies. PfPIMMS43 is a critical surface protein for the parasite's development within the mosquito, specifically during the transition from ookinete to oocyst, and aids in evading the mosquito's immune response. Building on previous research demonstrating the potential of polyclonal antibodies against PfPIMMS43, this study successfully developed and characterized high-affinity nanobodies derived from llamas. These nanobodies were shown to significantly reduce both the intensity and prevalence of P. falciparum infection in Anopheles mosquitoes using both laboratory and field strains of the parasite. The study mapped the binding epitopes of the nanobodies to conserved regions in the second half of PfPIMMS43, confirming epitope accessibility. These findings establish PfPIMMS43 as a promising target for malaria transmission-blocking interventions and propose an innovative strategy utilizing genetically modified mosquitoes expressing these nanobodies in conjunction with gene drive technology for enhanced malaria control and elimination efforts.Key Themes and Important Ideas:Malaria Transmission as a Target: The study emphasizes the importance of targeting the parasite's development within the mosquito vector to interrupt the human-to-mosquito and mosquito-to-human transmission cycle. This is presented as a crucial approach to complement existing malaria control measures, especially in the face of challenges like insecticide failure, climate change, and funding limitations. The transition from ookinete to oocyst in the mosquito midgut is identified as a "key developmental bottleneck" for the parasite.PfPIMMS43 as a Critical Transmission Target: The research highlights PfPIMMS43 as an "indispensable" surface protein for P. falciparum ookinetes and sporozoites. It is crucial for the ookinete-to-oocyst transition and plays a role in the parasite's ability to "evade the mosquito immune responses," specifically the complement-like system in the hemolymph. Previous studies, including those by the authors, had already indicated the potential of polyclonal antibodies targeting this protein in reducing transmission.Nanobodies as a Promising Intervention Tool: The study focuses on the development and application of VHH domain nanobodies as an alternative and potentially superior approach to conventional antibodies for transmission blocking. Nanobodies, derived from camelids and sharks, are described as "smaller, more easily produced monoclonal, heavy-chain variable (VHH) domain antibodies." Their advantages include:"small size (~15 kDa)""structural simplicity""strong binding affinity"Easily bioengineered for targeting parasite antigens in mosquito vectors.Development and Characterization of PfPIMMS43 Nanobodies: High-affinity nanobodies targeting PfPIMMS43 were successfully generated by immunizing llamas with recombinant PfPIMMS43. Nine nanobodies were selected based on variations in their antigen-binding regions (CDR1-3). Four nanobodies (G9, E5, C12, and E2) exhibited high nanomolar binding affinities to recombinant PfPIMMS43 (3, 5, 6, and 8 nM, respectively). These four nanobodies were also able to detect endogenous PfPIMMS43 protein expressed by P. falciparum ookinetes in infected mosquito midguts.Significant Transmission Blocking Activity (TRA): The developed nanobodies demonstrated significant transmission-reducing activity in mosquito feeding assays.In standard membrane feeding assays (SMFAs) using laboratory P. falciparum NF54 and An. coluzzii mosquitoes, the four high-affinity nanobodies (G9, E5, C12, and E2) significantly reduced oocyst numbers at a concentration of 100 µg/ml, with reductions ranging from 83% to 99%. Oocyst reduction was concentration-dependent.In direct membrane feeding assays (DMFAs) using natural P. falciparum isolates from gametocytaemic children in Tanzania and local An. gambiae mosquitoes, G9 and E5 (the two nanobodies with the highest affinities to recombinant PfPIMMS43) also showed significant TRA, with reductions of 99% and 79% at 100 µg/ml, respectively. Both nanobodies significantly reduced mosquito infection prevalence in field conditions.Epitope Mapping and Structural Insights: Epitope mapping revealed that the four nanobodies bind to "conserved regions in the second half of PfPIMMS43," specifically beyond amino acid residue 258. This suggests the C-terminal half of the protein is more immunogenic. G9 and E5 appear to recognize similar conformational ...
    続きを読む 一部表示
    13 分
  • Mosquito Prefoldin Targeting Blocks Plasmodium Transmission (March 2025)
    2025/03/07
    Briefing Document: Targeting the Mosquito Prefoldin–Chaperonin Complex to Block Plasmodium TransmissionCitation: Dong, Y., Kang, S., Sandiford, S.L. et al. Targeting the mosquito prefoldin–chaperonin complex blocks Plasmodium transmission. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-01947-3Date: Received - 22 November 2024 | Accepted - 27 January 2025 | Published - 06 March 2025Overview:This study investigates the role of the conserved Anopheles mosquito prefoldin (PFDN)–chaperonin (CCT/TRiC) system as a potential target for blocking the transmission of multiple Plasmodium species. The researchers demonstrate that disrupting this protein folding complex in mosquitoes, either through gene silencing or antibody inhibition, significantly reduces Plasmodium infection intensity and prevalence. The mechanism of action involves compromising the integrity of the mosquito midgut, leading to immune activation and the disruption of the parasite's immune evasion strategies. The findings suggest that the PFDN–chaperonin complex, particularly the PFDN6 subunit, holds promise as a multispecies transmission-blocking vaccine (TBV) target.Main Themes and Important Ideas/Facts:The Mosquito PFDN–Chaperonin Complex is Essential for Plasmodium Infection:The Plasmodium infection cycle in mosquitoes relies on various host factors in the midgut.The mosquito prefoldin complex is crucial for the proper folding of proteins and macromolecular complexes, including actin and tubulin, which are essential for cell division, motility, cytoskeletal stability, and signal transduction – all of which influence Plasmodium infection.Silencing any of the six PFDN subunits (Pfdn1-6) or the CCT4 subunit via RNA interference significantly reduced Plasmodium falciparum oocyst loads in the Anopheles gambiae midgut."Silencing any prefoldin subunit or its CCT/TRiC partner via RNA interference reduces Plasmodium falciparum oocyst loads in the mosquito midgut..."Co-silencing of different PFDN subunits did not have an additive effect, confirming that the complex functions as a unit in supporting parasite development.Targeting PFDN6 with Antibodies Blocks Plasmodium Transmission:Co-feeding mosquitoes with a PFDN6-specific antibody along with P. falciparum gametocytes resulted in a potent suppression of parasite infection at both the oocyst and sporozoite stages."Ingestion of purified anti-PFDN6 polyclonal antibody (IgG) resulted in a significant decrease in parasite loads (either at the oocyst or sporozoite stage) compared with control cohorts fed on rabbit anti-GFP antibody..."The level of inhibition achieved with anti-PFDN6 antibodies was comparable to that of leading TBV candidates like Pfs230 and Pfs25, as well as antibodies targeting mosquito proteins AgAPN1 and FREP1.Anti-PFDN6 antibody also effectively blocked P. falciparum transmission in Anopheles stephensi and Plasmodium vivax transmission in Anopheles dirus, indicating a broad-spectrum effect across different mosquito and parasite species.Active immunization of mice with recombinant PFDN6 protein resulted in antibodies that, when mosquitoes fed on the immunized, infected mice, significantly reduced Plasmodium berghei oocyst infection intensity and prevalence, supporting its potential as a TBV target.PFDN Supports Plasmodium Development After Ookinetes Invade the Midgut Epithelium:Antibody blocking assays showed no significant difference in ookinete numbers in the midgut lumen at 24 hours post-infection, but a significant decrease in oocyst loads was observed at 36 hours and 8 days.Injection of anti-PFDN6 antibody into the mosquito haemolymph also reduced oocyst numbers, suggesting an effect on the basal side of the midgut epithelium where oocysts develop."These results indicate that PFDN6 host factor function is exerted upon ookinete egress and oocyst formation on the basal side of the epithelium beneath the basal lamina."PFDN6 distribution largely overlapped with actin in the midgut epithelium, but it did not co-localize directly with the parasites, suggesting an indirect role in parasite development.Disruption of PFDN Compromises Midgut Integrity and Triggers Anti-Plasmodium Immunity:Attempting to create a Pfdn6 knockout mosquito line resulted in pre-adult lethality, likely due to cytoskeletal and gut integrity issues.Co-immunoprecipitation assays identified interactions between PFDN6 and actin, tubulin, and several extracellular matrix proteins, supporting its role in maintaining cellular and matrix integrity.Silencing Pfdn6 or co-feeding with anti-PFDN6 antibodies led to a "leaky gut," characterized by increased permeability and bacterial leakage from the midgut lumen into the haemolymph."Interfering with the PFDN–CCT/TriC chaperonin complex results in a cascade of events, including compromised gut integrity and disrupted extracellular matrix organization. The increased gut permeability leads to bacterial leakage and systemic infection, ultimately augmenting ...
    続きを読む 一部表示
    20 分